Requests for blood from unvaccinated donors is harming patients

A hospital in the United States has faced challenges after patients requesting blood transfusions specifically from donors unvaccinated against COVID-19 caused delays in treatment, leading to serious health risks. At Vanderbilt University Medical Center in Nashville, 15 patients or their caregivers requested directed blood donations from unvaccinated donors between January 2024 and December 2025. These requests, driven by concerns not supported by scientific evidence, resulted in treatment postponements, including one case where a patient’s dangerously low hemoglobin level posed a life-threatening risk. Directed blood donations, where blood is given by a chosen individual rather than sourced from anonymous volunteer donors, are operationally more complex and carry higher infection risks compared to routine blood supply. While such donations are permitted under strict conditions in countries like the UK and Australia, the US allows the practice more broadly but discourages it. The vaccination status of anonymous donors is not recorded or disclosed, making these requests difficult to fulfill and causing delays that can jeopardize patient safety. The resurgence of directed donations linked to COVID-19 vaccine hesitancy echoes patterns seen during the HIV/AIDS epidemic in the 1980s and 1990s. Despite extensive research confirming the safety and efficacy of mRNA COVID-19 vaccines, misinformation and conspiracy theories have fueled fears about vaccine side effects, including unfounded claims about fertility and other health issues. Experts emphasize that the blood supply is highly regulated and screened, and there is no evidence that blood from unvaccinated donors is safer or more effective for transfusions. This situation highlights the broader public health challenge posed by vaccine misinformation and its impact on medical practices. Delays in transfusions caused by unfounded demands for unvaccinated blood not only strain healthcare resources but also endanger patients who rely on timely and safe blood products. Medical professionals continue to advocate for reliance on scientifically validated protocols to ensure patient safety and maintain the integrity of the blood supply.